A second test for COVID-19, developed by University of Minnesota Medical School researchers, will play a role in the state’s plan to reopen Minnesota.  This test looks for antibodies generated after exposure to the virus, and combined with the University’s diagnostic (PCR) test, helps categorize those tested into four categories—information that will equip the state to confidently send Minnesotans back to work.  

"Together, they are informative if you do them both in the same person,” said Amy Karger, MD, PhD, an assistant professor in the Department of Laboratory Medicine and Pathology. She leads the team at the University’s Advanced Research and Diagnostic Laboratory (ARDL) that brought the test from a research setting into clinical use.  Full story by Angel Mendez here.